home / stock / gsd:cc / gsd:cc news


GSD:CC News and Press, Devonian Health Group Inc.

Stock Information

Company Name: Devonian Health Group Inc.
Stock Symbol: GSD:CC
Market: TSXVC
Website: groupedevonian.com

Menu

GSD:CC GSD:CC Quote GSD:CC Short GSD:CC News GSD:CC Articles GSD:CC Message Board
Get GSD:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

GSD:CC - Devonian Health Group GAAP EPS of -$0.81

2026-03-26 14:58:54 ET More on Devonian Health Group Financial information for Devonian Health Group Read the full article on Seeking Alpha For further details see: Devonian Health Group GAAP EPS of -$0.81

GSD:CC - Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026

Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026 Canada NewsWire (all amounts are in Canadian dollars) Quarter ended January 31, 2026, net loss of $2.2 million dollars, ($0.81) per share Six months ended ...

GSD:CC - Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects

Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects PR Newswire QUEBEC , Feb. 19, 2026 /PRNewswire/ - Devonian Health Group Inc. ("Devonian" or the Com...

GSD:CC - Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls

Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls Canada NewsWire QUEBEC , Feb. 17, 2026 /CNW/ - Devonian Health Group Inc. ("Devonian" or the Company) ( TSXV: GSD) (OTCQB: DVHGF) today announced that a propri...

GSD:CC - Devonian reports additional molecular data from MASH liver study

Devonian reports additional molecular data from MASH liver study Canada NewsWire Gene expression analysis from the STAM mouse model attributes Thykamine™ with dose-dependent anti-MASH, anti-inflammatory and anti-fibrosis molecular effects in liver QUÉBEC , Feb. 12, ...

GSD:CC - DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY

DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY Canada NewsWire Positive results from the Bleomycin Pulmonary Fibrosis mouse model in vivo study attributing Thykamine™ with anti-fibrotic effects in lungs Compelling results compared to Pirfenidone, a...

GSD:CC - DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT

DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT Canada NewsWire QUÉBEC , Feb. 2, 2026 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focuse...

GSD:CC - Canadian Companies Moving the Markets, Evening edition
Fri, Jan 23, 2026 as of 4:00 pm ET

A look at the top 10 most actives in Canada Osisko Metals Incorporated (OM) rose 6.7% to $0.95 on volume of 25,558,763 shares BetaPro Natural Gas Inverse Leveraged Daily Bear ETF (HND) fell 7.5% to $4.31 on volume of 23,838,947 shares Wallbridge Mining Company Limited (WM) rose 9.1% to $0.1...

GSD:CC - DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING

DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING Canada NewsWire QUÉBEC , Jan. 20, 2026 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that, in connect...

GSD:CC - Devonian Health Group Announces Grant of Stock Options

Devonian Health Group Announces Grant of Stock Options Canada NewsWire QUEBEC , Dec. 19, 2025 /CNW/ - Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical Company specializing in the development of prescri...

Next 10